Anavex Life Sciences Corp (AVXL)

[Doktornolittle]

Significance of "Precision Medicine" is understated. In this proposed trial the advantage to the 20% of patients that will be left out is not just the ability to try other treatments. Being left out opens a market and thus an incentive, and thus cash for development of new treatments for that 20%. That is why this type of patient screening is not just smarter, but more ethical.